Replies to post #146474 on Biotech Values

[DewDiligence]

Correction to #msg-78117290: The $28M MNTA receives from BAX on FoB compounds #3-#6 comes later—when BAX actually licenses the compounds at the PoC stage. This is new info that wasn’t previously disclosed.